The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies

Author:

Barker Timothy H.12ORCID,Hasanoff Sabira2ORCID,Aromataris Edoardo1ORCID,Stone Jennifer1,Leonardi-Bee Jo3,Sears Kim4,Habibi Nahal1,Klugar Miloslav56,Tufanaru Catalin7,Moola Sandeep8,Liu Xian-Liang9,Munn Zachary2ORCID

Affiliation:

1. JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia

2. Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, The University of Adelaide, Adelaide, SA, Australia

3. The Nottingham Centre for Evidence Based Healthcare: A JBI Centre of Excellence, School of Medicine, University of Nottingham, Nottingham UK

4. Queen’s Collaboration for Health Care Quality: A JBI Centre of Excellence, Queen’s University, Kingston, Ontario, Canada

5. Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic

6. Center for Evidence-Based Education and Arts Therapies: A JBI Affiliated Group, Faculty of Education, Palacký University Olomouc, Olomouc, Czech Republic

7. Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie University, Sydney, NSW, Australia

8. Health Economics and Value Assessment, Sanofi Healthcare India Pvt Ltd

9. School of Nursing and Health Studies, Hong Kong Metropolitan University, Homantin, Kowloon, Hong Kong SAR, China

Abstract

Cohort studies are a robust analytical observational study design that explore the difference between two different cohorts on an outcome, differentiated by their exposure status. Despite being observational in nature, they are often included in systematic reviews of effectiveness, particularly when randomized controlled trials are limited or not feasible. Like all studies included in a systematic review, cohort studies must undergo a critical appraisal process to assess the extent to which a study has considered potential bias in its design, conduct, or analysis. Critical appraisal tools facilitate this evaluation. This paper introduces the revised critical appraisal tool for cohort studies, completed by the JBI Effectiveness Methodology Group (EMG), who are currently revising the suite of JBI critical appraisal tools for quantitative study designs. The revised tool responds to updates in methodological guidance from the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group and reporting guidance from PRISMA 2020, providing a robust framework for evaluating risk of bias in a cohort study. Transparent and rigorous assessment using this tool will assist reviewers in understanding the validity and relevance of the results and conclusions drawn from a systematic review that includes cohort studies. This may contribute to better evidence-based decision-making in health care. This paper discusses the key changes made to the tool, justifications for these changes, and provides practical guidance on how this tool should be interpreted and applied by systematic reviewers.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference27 articles.

1. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool;Munn;JBI Evid Synth,2020

2. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration;Liberati;BMJ,2009

3. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences;Munn;BMC Med Res Methodol,2018

4. Determining the level of evidence: experimental research appraisal;Glasofer;Nurs Crit Care,2019

5. Conducting systematic reviews of association (etiology): The Joanna Briggs Institute’s approach;Moola;JBI Evid Implement,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3